Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-007772
Filing Date
2025-04-30
Accepted
2025-04-30 16:15:32
Documents
20
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 562035
2 GRAPHIC formpre14a_001.jpg GRAPHIC 3009
3 GRAPHIC formpre14a_002.jpg GRAPHIC 2962
4 GRAPHIC formpre14a_003.jpg GRAPHIC 4364
5 GRAPHIC proxy_001.jpg GRAPHIC 143043
6 GRAPHIC proxy_002.jpg GRAPHIC 158373
  Complete submission text file 0001641172-25-007772.txt   1640217

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bfri-20241231.xsd EX-101.SCH 3434
8 XBRL DEFINITION FILE bfri-20241231_def.xml EX-101.DEF 5355
9 XBRL LABEL FILE bfri-20241231_lab.xml EX-101.LAB 52569
10 XBRL PRESENTATION FILE bfri-20241231_pre.xml EX-101.PRE 39423
22 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 4141
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40943 | Film No.: 25895460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)